Journal Club

What is PSI's Pharmaceutical Statistics Journal Club?

PSI's Pharmaceutical Statistics Journal Club is a free-to-attend virtual meeting which takes place quarterly. PSI members and non-members alike are welcome to join the meetings. Journal Club meetings feature papers from PSI's official journal  Pharmaceutical Statistics which is published by John Wiley & Sons, Ltd. The authors of two papers are invited to present their work and each presentation is followed by a discussion.

The full version of the papers being presented at each meeting are freely available to all for a period around the Journal Club meeting date. The details of upcoming meetings will always be available on this page.

journal_2

Past Journal Club Meetings

Journal Club meetings are recorded and made available via psiweb.org. Individual presentations and the audio recordings can be accessed from psiweb.org shortly after the event. 

Click here for details of all previous meetings.

How does PSI's Pharmaceutical Statistics Journal Club work?

  • Journal Club meetings are held quarterly and last 1½ hours.
  • Two papers will be selected from Pharmaceutical Statistics and authors will be invited to present their papers (20 mins) followed by discussion (25 mins) for each paper.
  • Attendees dial into an interactive web facility or through a TC, to follow along with the speaker.
  • Papers and slides will be available to download beforehand from this page. 
  • These TCs are open to both PSI & non-PSI members. Please register and block out the date and time in your calendar.
  • Audio recordings will be available shortly after the TCs to download should you wish to catch up on the event or just listen again.

Further information

For further information or to provide feedback on PSI's Pharmaceutical Statistics Journal Club, please contact journalclub@psiweb.org.

Further details on Wiley, sponsor of PSI's PST Journal Clubs can be found at www.wiley.com. For details of other PSI Events please visit the events page, or for information on joining PSI please click here.

Upcoming Events

PSI Webinar: Master protocols - theory, application and regulatory considerations

For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.

Introduction To Industry Training Course 2020

The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. The start of the 2020-2021 course will be delayed until face-to-face meetings with up to 30 people are permitted and companies are allowing travel again.

PSI Webinar: Patient preference studies

In this webinar you will hear an introduction to what a patient preference study is as well as an overview of where this type of study can inform regulatory decision making. This will be followed by 2 examples looking at potential approaches to eliciting patient preference.

PSI Vaccine SIG Webinar: Statistical Topics on COVID-19 Therapeutic and Vaccine Clinical Trials

We are delighted to be joined by Frank Harrell who will present 'Sequential Bayesian Designs for Rapid Learning in COVID-19 Therapeutic Trials'; and also by Dean Follmann, who will present on 'Statistical Aspects of COVID-19 Vaccine Trials'. Join us for this insightful and highly topical webinar.

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

Latest Jobs

Senior Research Statistician

As a member of the Statistical Sciences and Modeling (SSM) group, provide statistical technical support to projects on complex problems and methods.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.